Yun Long

This inventor holds 35 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Cancer Inhibitors. Top assignees: Araxes Pharma LLC, Capella Therapeutics, Inc., Ligand Pharmaceuticals, Inc.. Active years: 2010-2025.

USPTO Granted Patents = 35 (Patent Applications = 7)

% Patents Active = 97.1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 495(Granted Patents)

Company Filing History:

Capella Therapeutics, Inc.

patents

1 out of 139

Ligand Pharmaceuticals, Inc.

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

KRAS G12C

Benzimidazole

Cancer Treatment

Inhibitors

Quinazoline

Tyrosine Kinase

Pharmaceutical Compositions

Heterocyclic Compounds

Androgen Receptor Modulators

Fused-Tricyclic

EGFR Activity

Substituted Compounds

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50490 - Substituted quinazoline compounds and methods of use thereof (2025-07-15),

2. 12234244 - Substituted piperazines as inhibitors of KRAS G12C (2025-02-25),

3. 11878985 - Substituted quinazolines as inhibitors of KRAS G12C (2024-01-23),

4. 11787788 - Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof (2023-10-17),

5. 11713322 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2023-08-01),

6. 11427565 - Benzimidazoles for use in the treatment of cancer and inflammatory diseases (2022-08-30),

7. 11242352 - Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer (2022-02-08),

8. 11021470 - 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof (2021-06-01),

9. 10975071 - Inhibitors of KRAS G12C mutant proteins (2021-04-13),

10. 10927125 - Substituted cinnolines as inhibitors of KRAS G12C (2021-02-23),

11. 10882847 - Inhibitors of KRAS G12C mutant proteins (2021-01-05),

12. 10875842 - Inhibitors of KRAS G12C mutant proteins (2020-12-29),

13. 10858343 - Inhibitors of KRAS G12C mutant proteins (2020-12-08),

14. 10829458 - Substituted quinazoline compounds and methods of use thereof (2020-11-10),

15. 10730867 - Inhibitors of KRAS G12C mutant proteins (2020-08-04),

Title: Inventor Yun Long - Revolutionizing Technology in San Diego

Introduction: Yun Long is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yun Long holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Yun Long has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Yun Long has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and inventions.

Conclusion: Yun Long's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs in San Diego and beyond.